ReviewPharmaceutical medicine2023

Practical Considerations for the Implementation and Monitoring of Risk Minimisation Measures for High-Risk Teratogenic Medicines.

Marion Mueller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.